Direct stick embolization (DSE) of high-flow peripheral arteriovenous malformations (AVMs) has previously been reported using n-butyl cyanoacrylate and ethanol. The use of ethylene vinyl alcohol copolymer (Onyx; Covidien, Plymouth, Minn) through this delivery route has been extremely limited, particularly in the peripheral interventional realm, owing to concerns about technique and conduit for delivery, skin discoloration, and ulceration. We describe three patients with relatively focal, symptomatic, congenital high-flow AVMs of the upper and lower extremity treated successfully by multifaceted approaches including transvenous coil embolization of the nidus venous outflow, transarterial embolization, and DSE of the AVM nidus with Onyx. Successful delivery of Onyx into the AVM nidus was achieved without nontarget embolization. Sustained symptomatic relief without recurrence or associated complications was achieved at 1 month, 3 months, and 6 months of follow-up. Nidus embolization is a key technical maneuver for optimal treatment of high-flow AVMs, although it is not always easily achievable by the transarterial route in more extensive, convoluted angioarchitectural varieties. With appropriate technical considerations and precautionary measures, Onyx can be safely and effectively delivered through DSE into the AVM nidus with satisfactory short-term and midterm clinical outcomes. This maneuver expands the armamentarium of the treating vascular surgeon facing complicated peripheral AVMs. (J Vasc Surg 2017;65:1223-8.) Arteriovenous malformations (AVMs) represent pathologic connections between arteries and veins anywhere upstream of the capillary level. Within the extremities, congenital AVMs often contain a nidus situated between the feeding arteries and draining veins. This nidus represents a convoluted conglomerate of tortuous blood vessels with poorly differentiated endothelial cells. A key maneuver for successful AVM treatment is nidus penetration and elimination.
Arteriovenous malformations (AVMs) represent pathologic connections between arteries and veins anywhere upstream of the capillary level. Within the extremities, congenital AVMs often contain a nidus situated between the feeding arteries and draining veins. This nidus represents a convoluted conglomerate of tortuous blood vessels with poorly differentiated endothelial cells. A key maneuver for successful AVM treatment is nidus penetration and elimination. [1] [2] [3] [4] This is best achieved by superselective catheterization through a coaxial, microcatheter-based platform. This is often achievable through the conventional antegrade transarterial route. In certain instances, however, innumerable arterial feeders are involved in nidus vascularization, rendering this approach nearly impossible for adequate treatment.
In such circumstances, direct percutaneous access of the nidus can be performed under roadmap guidance with direct stick embolization (DSE). The embolic agents used most commonly with DSE have been ethanol and n-butyl cyanoacrylate. 1, 5 Another commonly used agent in AVM treatment is the slowly polymerizing agent Onyx (Covidien, Plymouth, Minn). It has been well described in both transarterial and, more rarely, retrograde transvenous approaches to AVM embolization. 1, 4, 6, 7 However, the technique of DSE of extremity AVMs with Onyx has not been extensively described previously, probably secondary to concerns about skin staining, pain, ulceration, and nuances of emulsion preparation and delivery. Through three case reports, we describe our approach for successful DSE of symptomatic extremity AVMs using Onyx. Consent to publish this case series was obtained from the patients.
CASE REPORTS

Patient 1
A 35-year-old woman was referred for evaluation of a congenital high-flow AVM of the hypothenar eminence of the right (dominant) hand, which had become progressively more painful after pregnancy. In addition to pain, the patient complained of distal digital paresthesias and hand weakness with digital flexion and adduction maneuvers. She had presented with a diagnostic
angiogram from an outside facility, which had confirmed a Yakes IIb AVM with an intervening nidus situated between arterial feeders from the radial artery and degenerated draining veins into the superficial cephalic system (Fig 1; Table) . 8, 9 Technical details. A 5F short sheath was placed antegrade into the brachial artery at the elbow. Angiography demonstrated little if any contribution of the ulnar artery to the AVM nidus, the majority of which appeared to arise from the distal branches of the radial artery. Access was gained into the right radial artery. Once the AVM flow was diminished, cannulation of the arterial side of the malformation was performed coaxially using a 5F Berenstein catheter, 2.7F Berenstein tip Direxion microcatheter, and 0.014-inch Fathom wire. Access to the nidus' feeding vessels was obtained. Embolization of the nidus was performed using 2.5 mL of Onyx 18 (lower viscosity), resulting in excellent deposition of Onyx into this portion of the nidus. Fig 1. A, Arteriovenous malformation (AVM) of the right hypothenar region. B, Arteriogram reveals prominent nidus of the palmar arch fed by the radial artery with decreased distal flow. C, Transvenous coil embolization of venous drainage was performed (arrow), deposited in nidus venous drainage tract. This was followed by transarterial and direct percutaneous nidus embolization using Onyx (arrowhead). There is significant improvement in digital flow with no evidence of nontarget embolization. D, Follow-up examination shows markedly reduced bulge at the hypothenar eminence without skin staining or ulceration at 12 months following direct stick embolization (DSE) with Onyx.
There was no evidence of nontarget embolization. The microcatheter was removed, and an attempt was made to recannulate another major feeding vessel contributing to the nidus of the AVM. However, given the extreme tortuosity, this was deemed not possible.
Once supraselective angiographic delineation of the AVM nidus is performed, a roadmap is obtained and used as an imaging guide to help direct needle insertion into the AVM nidus at the time of direct stick access. A micropuncture needle was used, and Onyx was then infused into the AVM nidus and the needle track was plugged with a Surgiflo collagen matrix (Ethicon, Somerville, NJ) with no evidence of extravasation onto the skin. Collagen matrix is injected into the delivery apparatus on completion of embolization and during delivery apparatus withdrawal. One can correlate needle tip location with magnetic resonance imaging (MRI) delineation of the AVM nidus. Ultrasound guidance can be helpful, but blind access into the area of the malformation can also be safely performed in experienced hands with confirmation of intraluminal placement on angiography.
Completion angiography showed significant improvement in embolization of the high-flow AVM with no evidence of nontarget embolization or compromise of the digital arteries (Fig 1) .
Procedural outcome. The patient tolerated the procedure well, without any complications, and was discharged home in stable condition, without symptoms, on postoperative day 1.
She was seen in follow-up at 1 month, 3 months, and 6 months, with no further pain or discomfort. She will be monitored with repeated computed tomography angiography annually.
Patient 2
A 32-year-old woman with a high-flow AVM of the medial plantar aspect of the right foot underwent attempted surgical rial feeders into the AVM nidus. The decision was made to proceed with DSE using Onyx, which was achieved successfully without nontarget embolization (Fig 2) . Healing of the ulcer was achieved with improved but persistent chronic local pain partially attributable to prior surgery. She required two more sessions of DSE during the subsequent 6 months for maintained quiescence of the AVM.
Patient 3
An 18 (Fig 3) . Local ulcer healing was achieved within 1 month of DSE with improved local pain and no further bouts of hemorrhage.
DISCUSSION
Nidus obliteration is imperative in effective treatment of congenital AVMs. Superselective nidus penetration for delivery of the embolic agent of choice can be performed through the transarterial, transvenous, or direct puncture (DSE) routes. [1] [2] [3] [4] [5] In more complicated angioarchitectural varieties, a combination of these approaches may be necessary. The more conventional transarterial route is not always possible because of factors such as extreme tortuosity of feeding vessels, vasospasm, and presence of innumerable arterial feeders. Therefore, familiarity with the unique angioarchitecture of the AVMdwhich can evolve between staged sessions of embolization mainly by recruitment of collateral arterial feeders and subsequent development of venous drainersdis essential in strategizing one's (Table) . 5, 8, 9, 11 Whereas ultimately the route of therapy is determined by the experienced operator, certain AVM configurations lend themselves more effectively to certain therapeutic modalities over others. For example, Yakes Ia AVMs represent a more direct fistulous connection between the involved artery and vein. These entities are best treated by proximal occluding devices, such as coils and plugs. DSE is an invaluable technique that can be used alone or in conjunction with other approaches. Location of the lesion and presence of overlying anatomic structures play an important role in determining the feasibility and safety of this technique, although most extremity AVMs tend to be easily accessible percutaneously. Transarterial roadmap guidance is preferred but not absolutely necessary for successful delivery of this technique. Familiarity with the polymerization properties and toxicity profile of the embolic agent used is essential for successful delivery of therapy with avoidance of potentially disastrous complications associated with extravasation and nontarget embolization. 1 Currently, technical success and clinical success have been reported with n-butyl cyanoacrylate and ethanol DSE. [12] [13] [14] [15] Although percutaneous use of Onyx has been reported in rare case reports involving the head and dural sinus, the technique of Onyx DSE of extremity AVMs has not been extensively discussed and reported in the English literature. [15] [16] [17] [18] [19] [20] This limited use can be due to the need for dimethyl sulfoxide (DMSO) compatibility of the delivery apparatus and concerns for skin staining and ulceration with more superficial AVMs. DMSO is a chemical solvent that prevents premature polymerization of Onyx within the delivery apparatus before contact with ionic blood. Given the paucity of clinical data and lack of prospective randomized trials, no stern recommendation can currently be made regarding an embolic agent of choice, and this decision remains at the discretion of the treating physician. We prefer Onyx, given its slowly polymerizing properties, which render it an ideal agent for nidus penetration with little toxicity and decreased risk of nontarget embolization. It can also be delivered in a highly controlled manner under direct visualization. Other suitable and frequently used agents include absolute ethanol and the rapidly polymerizing agent n-butyl cyanoacrylate.
We have found the typical 21-gauge micropuncture needles used for vascular access to be DMSO compatible. The dead space for these or other DMSOcompatible delivery conduits can be easily measured before the procedure with saline flush. Precise placement of the needle intraluminally within the nidus network is the most challenging aspect of this technique. Roadmap guidance can provide a rough estimate of the location of the nidus. Once within the vicinity, however, care must be taken to ensure that the needle tip is intraluminal within a corresponding nidus vessel. This step may require use of short connection tubings for contrast-enhanced fluoroscopic verification. Once it is intraluminal, Onyx must be delivered directly through the needle by detaching the connection tubings, which are not, for the most part, DMSO compatible. This step is crucial as manipulations can lead to needle tip movements and extravasation. Positioning of the operator in an ergonomically comfortable position that maximizes manual stability and minimizes needle tip movement is essential. We prefer the use of lower viscosity Onyx 18 during DSE for better flow and more distal penetration of the nidus. Furthermore, through this route, we are not concerned about delivery equipment tip adherence and detachment secondary to polymerization and cast formation of Onyx. Once adequate nidus penetration is achieved and confirmed on fluoroscopy, the needle entry track is plugged with a collagen matrix emulsion, followed by gentle manual compression to ensure that the injected Onyx does not flow back and come in contact with the overlying skin. The use of lead-impregnated gloves is essential during Onyx DSE to minimize radiation exposure to the operator.
CONCLUSIONS
DSE of extremity AVMs can be performed safely with Onyx and represents yet another effective approach to the treatment of complex AVMs in the setting of compromised inflow access. 
